MAPT and Alzheimer disease: Assessments were made for gut microbiome composition, fecal short-chain fatty acids (SCFAs) and AD markers in cerebrospinal fluid (CSF), which included Aβ-40, Aβ-42, total tau and phosphorylated tau-181 (tau-p181), both before and after the dietary interventions.